stem cells

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Classified as: Takeda, stem cells, ALS, hiPSCs, amyotrophic lateral sclerosis, open science, C-BIGR, Open Drug Discovery Platform
Published on: 4 Dec 2017

Microglia, critical to Alzheimer’s research, can now be produced artificially

The quest for better understanding of Alzheimer’s disease (AD) has a powerful new tool at its disposal — the ability to artificially generate brain cells that have been shown to play an important role in the disease function.

Classified as: microglia, MS, stem cells, Alzheimer's disease, iPSC, Jack Antel, Luke Healy
Published on: 16 May 2017

Two researchers at the Montreal Neurological Institute and Hospital (MNI) of McGill University have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.

Classified as: genetics, stem cells, ARSACS, Charlevoix-Saguenay, University of Saskatchewan, ARSACS Foundation, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Neuro Giving
Published on: 24 Nov 2016

Millions of Canadians are affected by diseases of the brain such as ALS, Parkinson’s and brain tumours, for which there are limited treatments and no cures. By 2020, neurological conditions will become the leading cause of death and disability.

Classified as: Parkinson's, stem cells, induced pluripotent stem cells, iPSCs, neuron, skin cells
Category:
Published on: 2 Apr 2015

Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease

Classified as: neuroscience, brain, treatment, neurological, Multiple Sclerosis, Amit Bar-Or, bone marrow, MS, stem cells, transplant
Category:
Published on: 26 Mar 2013